 Melissa Mahoney
Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyethylene Glycols | 17 | 2015 | 652 | 2.960 |
Why?
| | Neurons | 13 | 2011 | 1639 | 1.440 |
Why?
| | Biocompatible Materials | 9 | 2014 | 436 | 1.320 |
Why?
| | Tissue Engineering | 9 | 2014 | 441 | 1.310 |
Why?
| | Hydrogels | 9 | 2015 | 703 | 1.190 |
Why?
| | Embryonic Stem Cells | 4 | 2010 | 124 | 1.110 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 4 | 2011 | 80 | 1.010 |
Why?
| | Interleukin-10 | 5 | 2016 | 310 | 0.980 |
Why?
| | Cell Culture Techniques | 10 | 2015 | 372 | 0.840 |
Why?
| | Lactic Acid | 6 | 2012 | 303 | 0.780 |
Why?
| | Rats | 26 | 2016 | 5570 | 0.770 |
Why?
| | Neuroglia | 5 | 2011 | 173 | 0.710 |
Why?
| | Cell Survival | 9 | 2015 | 1092 | 0.640 |
Why?
| | Fibrin | 2 | 2010 | 84 | 0.610 |
Why?
| | Cell Differentiation | 9 | 2010 | 2037 | 0.600 |
Why?
| | Spinal Cord | 2 | 2012 | 384 | 0.550 |
Why?
| | Insulin-Secreting Cells | 3 | 2014 | 390 | 0.510 |
Why?
| | Cells, Cultured | 12 | 2011 | 4110 | 0.500 |
Why?
| | Brain-Derived Neurotrophic Factor | 4 | 2011 | 151 | 0.490 |
Why?
| | Brain Tissue Transplantation | 4 | 2001 | 19 | 0.490 |
Why?
| | Genetic Therapy | 5 | 2016 | 313 | 0.480 |
Why?
| | Brain | 7 | 2011 | 2934 | 0.460 |
Why?
| | Rats, Sprague-Dawley | 10 | 2011 | 2521 | 0.460 |
Why?
| | Cell Proliferation | 8 | 2010 | 2489 | 0.450 |
Why?
| | Neuralgia | 2 | 2016 | 148 | 0.420 |
Why?
| | Collagen | 2 | 2007 | 450 | 0.410 |
Why?
| | Drug Delivery Systems | 4 | 2010 | 380 | 0.400 |
Why?
| | Nerve Tissue | 3 | 2009 | 7 | 0.370 |
Why?
| | Animals | 32 | 2016 | 37948 | 0.370 |
Why?
| | Pancreas | 2 | 2015 | 341 | 0.340 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 973 | 0.340 |
Why?
| | Injections, Spinal | 5 | 2016 | 120 | 0.330 |
Why?
| | Fibroblast Growth Factor 2 | 2 | 2011 | 93 | 0.330 |
Why?
| | Nerve Growth Factor | 3 | 2006 | 34 | 0.320 |
Why?
| | Microscopy, Confocal | 5 | 2015 | 317 | 0.310 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2010 | 76 | 0.310 |
Why?
| | Fetus | 3 | 2006 | 800 | 0.300 |
Why?
| | DNA | 4 | 2010 | 1447 | 0.300 |
Why?
| | Free Radical Scavengers | 1 | 2009 | 82 | 0.300 |
Why?
| | Gene Transfer Techniques | 2 | 2010 | 186 | 0.300 |
Why?
| | Guided Tissue Regeneration | 1 | 2009 | 13 | 0.290 |
Why?
| | Thrombin | 1 | 2010 | 167 | 0.290 |
Why?
| | Free Radicals | 1 | 2009 | 110 | 0.290 |
Why?
| | Neovascularization, Physiologic | 1 | 2010 | 191 | 0.290 |
Why?
| | Fibrinogen | 1 | 2010 | 181 | 0.290 |
Why?
| | Collagen Type I | 1 | 2009 | 143 | 0.290 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2010 | 133 | 0.290 |
Why?
| | Plasmids | 1 | 2010 | 375 | 0.290 |
Why?
| | Fetal Tissue Transplantation | 4 | 2010 | 33 | 0.280 |
Why?
| | Tissue Scaffolds | 1 | 2010 | 223 | 0.270 |
Why?
| | Central Nervous System | 1 | 2010 | 279 | 0.260 |
Why?
| | Polyglycolic Acid | 4 | 2012 | 44 | 0.260 |
Why?
| | Islets of Langerhans | 2 | 2010 | 842 | 0.250 |
Why?
| | Stem Cells | 3 | 2010 | 621 | 0.240 |
Why?
| | Polymers | 2 | 2010 | 492 | 0.240 |
Why?
| | Choline O-Acetyltransferase | 3 | 2001 | 26 | 0.230 |
Why?
| | Neurites | 2 | 2005 | 50 | 0.220 |
Why?
| | Materials Testing | 4 | 2009 | 348 | 0.220 |
Why?
| | Retinal Degeneration | 3 | 2010 | 39 | 0.220 |
Why?
| | Behavior, Animal | 3 | 2016 | 521 | 0.220 |
Why?
| | Pain | 1 | 2010 | 785 | 0.210 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2005 | 79 | 0.210 |
Why?
| | Endothelial Cells | 2 | 2010 | 864 | 0.210 |
Why?
| | Glucose | 1 | 2009 | 1033 | 0.210 |
Why?
| | Retina | 3 | 2010 | 319 | 0.180 |
Why?
| | Nerve Growth Factors | 2 | 1999 | 78 | 0.180 |
Why?
| | Immunohistochemistry | 3 | 2011 | 1705 | 0.180 |
Why?
| | Cell Count | 3 | 2011 | 320 | 0.170 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2011 | 17 | 0.170 |
Why?
| | Cell Shape | 2 | 2010 | 56 | 0.160 |
Why?
| | Models, Biological | 2 | 2006 | 1811 | 0.160 |
Why?
| | Particle Size | 3 | 2011 | 401 | 0.150 |
Why?
| | Porosity | 2 | 2010 | 95 | 0.150 |
Why?
| | PC12 Cells | 3 | 2009 | 42 | 0.150 |
Why?
| | Cell Aggregation | 3 | 2015 | 19 | 0.140 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 501 | 0.130 |
Why?
| | Apoptosis | 3 | 2010 | 2397 | 0.120 |
Why?
| | Gene Expression Regulation | 3 | 2010 | 2591 | 0.120 |
Why?
| | Stem Cell Transplantation | 2 | 2007 | 190 | 0.120 |
Why?
| | Surface Properties | 2 | 2009 | 397 | 0.120 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 68 | 0.110 |
Why?
| | Human Embryonic Stem Cells | 1 | 2015 | 24 | 0.110 |
Why?
| | Enzymes | 1 | 2015 | 65 | 0.110 |
Why?
| | Cell Size | 2 | 2015 | 92 | 0.100 |
Why?
| | Fatigue | 1 | 2016 | 363 | 0.100 |
Why?
| | Prosthesis Implantation | 2 | 2011 | 154 | 0.090 |
Why?
| | Cell Line | 2 | 2010 | 2821 | 0.090 |
Why?
| | Astrocytes | 2 | 2011 | 228 | 0.090 |
Why?
| | Microspheres | 4 | 2010 | 142 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 324 | 0.090 |
Why?
| | Dipeptides | 1 | 2011 | 56 | 0.080 |
Why?
| | Microglia | 2 | 2011 | 269 | 0.080 |
Why?
| | Alzheimer Disease | 2 | 1999 | 622 | 0.080 |
Why?
| | Epidermal Growth Factor | 1 | 2011 | 161 | 0.080 |
Why?
| | Cell Enlargement | 1 | 2010 | 8 | 0.080 |
Why?
| | Proteins | 1 | 1996 | 1016 | 0.080 |
Why?
| | Compressive Strength | 1 | 2010 | 72 | 0.080 |
Why?
| | 3T3 Cells | 1 | 2010 | 156 | 0.080 |
Why?
| | Molecular Weight | 1 | 2010 | 312 | 0.080 |
Why?
| | Pharmacokinetics | 1 | 2010 | 32 | 0.080 |
Why?
| | Parkinson Disease | 1 | 1996 | 600 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 141 | 0.080 |
Why?
| | Gels | 1 | 2010 | 85 | 0.080 |
Why?
| | Coculture Techniques | 1 | 2010 | 245 | 0.080 |
Why?
| | Mechanical Phenomena | 1 | 2010 | 81 | 0.080 |
Why?
| | Elastic Modulus | 1 | 2010 | 121 | 0.080 |
Why?
| | Geography | 1 | 2010 | 203 | 0.080 |
Why?
| | Polyesters | 1 | 2010 | 78 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 365 | 0.080 |
Why?
| | Vimentin | 1 | 2009 | 54 | 0.070 |
Why?
| | Glucose Transporter Type 2 | 1 | 2009 | 16 | 0.070 |
Why?
| | Esters | 1 | 2009 | 72 | 0.070 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 156 | 0.070 |
Why?
| | Time Factors | 2 | 2010 | 7140 | 0.070 |
Why?
| | Cat Diseases | 1 | 2009 | 25 | 0.070 |
Why?
| | Absorption | 1 | 2009 | 61 | 0.070 |
Why?
| | Extracellular Matrix | 2 | 2014 | 560 | 0.070 |
Why?
| | Aldehydes | 1 | 2009 | 141 | 0.070 |
Why?
| | Blood-Brain Barrier | 1 | 2010 | 155 | 0.070 |
Why?
| | Anxiety | 1 | 2016 | 1122 | 0.070 |
Why?
| | Insulin | 2 | 2009 | 2502 | 0.070 |
Why?
| | Plasma | 1 | 2010 | 223 | 0.070 |
Why?
| | Glutathione | 1 | 2010 | 366 | 0.070 |
Why?
| | Haplorhini | 1 | 2008 | 52 | 0.070 |
Why?
| | Mitogens | 1 | 2007 | 55 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1047 | 0.060 |
Why?
| | Humans | 12 | 2015 | 144667 | 0.060 |
Why?
| | Growth Substances | 1 | 2006 | 138 | 0.060 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1078 | 0.060 |
Why?
| | Mass Spectrometry | 1 | 2009 | 743 | 0.060 |
Why?
| | Regenerative Medicine | 1 | 2006 | 48 | 0.060 |
Why?
| | Diffusion | 1 | 2006 | 124 | 0.060 |
Why?
| | Mice | 4 | 2015 | 18261 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2019 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2007 | 1363 | 0.060 |
Why?
| | Resins, Synthetic | 1 | 2005 | 13 | 0.060 |
Why?
| | Biological Transport | 1 | 2006 | 418 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2010 | 894 | 0.050 |
Why?
| | Pain Management | 1 | 2009 | 410 | 0.050 |
Why?
| | Fibroblasts | 1 | 2010 | 1019 | 0.050 |
Why?
| | Biomimetic Materials | 1 | 2005 | 78 | 0.050 |
Why?
| | Cell Lineage | 1 | 2006 | 376 | 0.050 |
Why?
| | Cell Communication | 1 | 2006 | 325 | 0.050 |
Why?
| | Cell Polarity | 1 | 2005 | 137 | 0.050 |
Why?
| | Fluorescent Dyes | 1 | 2005 | 333 | 0.050 |
Why?
| | Nanoparticles | 1 | 2010 | 512 | 0.050 |
Why?
| | Macrophages | 1 | 2010 | 1496 | 0.040 |
Why?
| | Male | 6 | 2016 | 72431 | 0.040 |
Why?
| | Solubility | 1 | 2001 | 236 | 0.040 |
Why?
| | Evoked Potentials, Visual | 2 | 2010 | 42 | 0.040 |
Why?
| | Biopolymers | 1 | 1999 | 35 | 0.040 |
Why?
| | Drug Implants | 1 | 1999 | 83 | 0.040 |
Why?
| | Electrophysiology | 2 | 2010 | 218 | 0.040 |
Why?
| | Biotechnology | 1 | 1999 | 46 | 0.040 |
Why?
| | Superior Colliculi | 2 | 2010 | 44 | 0.040 |
Why?
| | Culture Media | 1 | 1999 | 163 | 0.040 |
Why?
| | Cytokines | 1 | 2006 | 2045 | 0.030 |
Why?
| | Animals, Genetically Modified | 2 | 2010 | 245 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 1999 | 184 | 0.030 |
Why?
| | Photic Stimulation | 2 | 2010 | 264 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3910 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 1999 | 150 | 0.030 |
Why?
| | Mathematics | 1 | 1996 | 100 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2016 | 85 | 0.030 |
Why?
| | Life Expectancy | 1 | 2016 | 72 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2016 | 132 | 0.030 |
Why?
| | Polymerization | 1 | 2015 | 130 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2016 | 399 | 0.020 |
Why?
| | Motor Activity | 1 | 2016 | 723 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2015 | 1154 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2136 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2909 | 0.020 |
Why?
| | Peptides | 1 | 2015 | 989 | 0.020 |
Why?
| | Cats | 1 | 2009 | 228 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2007 | 19 | 0.020 |
Why?
| | Head Movements | 1 | 2007 | 36 | 0.020 |
Why?
| | Motion Perception | 1 | 2007 | 20 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3523 | 0.020 |
Why?
| | Transcription Factors | 1 | 2015 | 1726 | 0.020 |
Why?
| | Graft Survival | 1 | 2009 | 510 | 0.020 |
Why?
| | Chronic Disease | 1 | 2009 | 1810 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2350 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 1999 | 35 | 0.010 |
Why?
| | Succinimides | 1 | 1999 | 21 | 0.010 |
Why?
| | Fluorescein | 1 | 1999 | 24 | 0.010 |
Why?
| | Dimerization | 1 | 1999 | 190 | 0.010 |
Why?
| | Drug Stability | 1 | 1999 | 169 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 1999 | 159 | 0.010 |
Why?
| | Polyvinyls | 1 | 1999 | 20 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 1999 | 232 | 0.010 |
Why?
| | Biodegradation, Environmental | 1 | 1999 | 87 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1999 | 268 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 335 | 0.010 |
Why?
| | Drug Carriers | 1 | 1999 | 132 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1999 | 580 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2007 | 4539 | 0.010 |
Why?
| | Kinetics | 1 | 1999 | 1602 | 0.010 |
Why?
| | Female | 2 | 2011 | 78304 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 11735 | 0.010 |
Why?
|
|
Mahoney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|